12 results on '"Sankey, Peter"'
Search Results
2. Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
3. Nivolumab and ipilimumab for metastatic prostate cancer with an immunogenic signature: The NEPTUNES multi-centre two-cohort, biomarker-selected phase 2 trial.
4. Multi-centre prospective evaluation of cognitive function in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or enzalutamide (ENZ): The ACE study.
5. PETRANHA: Phase 1/2 study of AZD5305 + novel hormonal agents in patients with metastatic prostate cancer–Interim safety and pharmacokinetic results.
6. Abstract LB004: Nivolumab (NIVO) and ipilimumab (IPI) treatment in prostate cancer with an immunogenic signature: cohort 1 of the NEPTUNES multi-centre, two-stage biomarker-selected Phase II trial
7. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters
8. Republished: Immune checkpoint inhibitor induced large vessel vasculitis
9. Abstract PO-040: The Effects of the COVID-19 pandemic on cancer patient encounters
10. Immune checkpoint inhibitor induced large vessel vasculitis
11. Nivolumab and ipilimumab treatment in prostate cancer with an immunogenic signature (NEPTUNES).
12. Republished: Immune checkpoint inhibitor induced large vessel vasculitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.